Showing posts with label BA. Show all posts
Showing posts with label BA. Show all posts

Wednesday, March 20, 2019

What We're Reading ~ 3/20/19


T. Rowe Price: The Man, The Company & The Investment Philosophy [Cornelius Bond]

How to take the outside view [McKinsey]

Pitch on short Tesla [Dropbox]

What is Amazon [Zack Kanter]

Allen Zhang on the key product principles of WeChat [WeChat]

KKR is too cheap [Yet Another Value Blog]

Buying is easy, selling is hard [Bloomberg]

In 12 minutes, everything went wrong: LionAir crash [NYTimes]

The SaaS busines model & metrics [Matrix Partners]

How an app for gamers went mainstream [The Atlantic]

The risk of low growth stocks: Prestige Brands [Intrinsic Investing]

Franchise value: video game IP vs movie IP [Medium]

The 20 craziest investment facts ever [Irrelevant Investor]

Netflix is the most intoxicating portal [NYTimes]

Farmbelt bankruptcies are soaring [WSJ]

ESPN's ex-President wants to build the Netflix of sports [Bloomberg]

Inside HBO's plan to win the streaming wars [Vanity Fair]

Interview with Twitter CEO Jack Dorsey [Rolling Stone]


Wednesday, January 30, 2019

What We're Reading ~ 1/30/19


Blue Ocean Strategy: How to Create Uncontested Market Space and Make the Competition Irrelevant [W. Chan Kim & Renee Mauborgne]]

Latest thoughts from Ray Dalio [LinkedIn]

Morgan Housel on what other industries teach us about investing [MicroCapClub]

Dominance of tech stocks: an evolve-or-die moment for world's great investors [Fortune]

A global tipping point: half the world is now middle class or higher [Brookings]

A look at Air Lease (AL) [Woodlock House]

Pitch on InterActive Corp (IAC) [LG's Musings]

AT&T wants to be big in entertainment but it has a $49 billion problem [WSJ]

Boeing's decision of the decade: does it build the 797? ]Bloomberg]

How Juul made vaping viral [Techcrunch]

Sports betting in the US: the rise of a billion dollar business [NYTimes]

Mukesh Ambani wants to be India's first internet tycoon [Economist]

How a former Canadian spy helps Wall Street mavens think better [NYTimes]

The best investments of 2018? Art, wine, and cars [WSJ]

A look back at the life of Jack Bogle [Vanguard]

The legacy of Herb Kelleher, co-founder of Southwest Airlines [Harvard Biz Review]


Wednesday, February 28, 2018

What We're Reading ~ 2/28/18


On decision regret [A Wealth of Common Sense]

Why competitive advantages die [Collaborative Fund]

Notes from the Wharton restructuring & distressed conference [Reddit]

The case against Google [NYTimes]

Consumer goods: big brands battle with the little guys [FT]

The end of the low volatility regime [13D]

Myths and facts about "risk parity" [FT Alphaville]

Inside Facebook's two years of hell [Wired]

How Softbank, world's biggest tech investor, throws around its cash [WSJ]

Canada's housing market flirts with disaster [FT]

Everything you need to know about 5G [IEEE Spectrum]

Inside T-Mobile's big, brash comeback [Fortune]

Boeing is killing it by squeezing its suppliers [Bloomberg]

From imitation to innovation: how China became a tech superpower [Wired]

Chinese tourists are taking over the earth [Bloomberg]

There's a global race to control batteries - and China is winning [WSJ]

Didi Chuxing took on Uber and won, now it's taking on the world [Wired]

Autonomous cars: no one wants to let Google win the war for maps all over again [Bloomberg]

Dyson bets on electric cars to shakeup industry [FT]

How to succeed in business?  Do less [WSJ]


Wednesday, October 30, 2013

Mark Kingdon's Thesis on Boeing & Aegerion Pharma: Invest For Kids Chicago

Next up in our notes from Invest For Kids Chicago 2013 is Mark Kingdon of Kingdon Asset Management.   He pitched two ideas: Aegerion Pharma (AEGR) and Boeing (BA).


Mark Kingdon's Presentation at Invest For Kids Chicago

•    $1.6 million dollars 30 years ago; 17% CAGR 30 years
•    Generally positive view on global economy and equities
•    Increasing auto and housing outlook

•    Special situations:

•    Idea #1: Aegerion Pharma (AEGR)
•    Drug is Juxtapid
•    Orphan drug for HOHF (ultra high cholesterol)
•    Original thought was 300 patients in US and 900 worldwide
•    Actually though TAM of 15,000 patients or more (no pediatric assumed)
•    $295,000 per year per patient leads to $25 EPS
•    Sell side is now upping patient forecast to 15,000
•    Upcoming testing in children, Japan is growing


•    Idea #2: Boeing (BA): thinks it's undervalued
•    5 years late and well over budget
•    First major plans designed from ground up since 1960’s
•    Terrific customer experience and better for carriers
•    787 is very economical to operate
•    (no rivets rather using special glue)
•    Boeing CEO – payback could be as low as two years.
•    Used to be 5% payback on a plane and now expected return is 30%
•    Airline industry is facing rising demand
•    8 year backlog for planes
•    2015 is mid-cycle
•    12 FCF (low end of 2015) x 14 multiple = 156 stock
•    Boeing has promised to return 80% of FCF to shareholders
•    Multiple should rise, backlog is strong


Check out the rest of the hedge fund presentations from Invest For Kids Chicago here.